Skip to content
★ Sign in to follow
KW

Kay Wagoner

Icagen, Inc.
Total declarations
18
Company
1
▲ Purchases (1 ops.)
€7,211
▼ Sales (1 ops.)
€291

Latest filing published 27 Sept 2011 for Icagen, Inc., €279k.

Insider track record

Disclosed buys
1
Disclosed sells
1
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Kay Wagoner: trading record in brief

Kay Wagoner is a declared insider of Icagen, Inc., with filings sourced from SEC (Form 4). The record holds 18 filings, for trades running from 1 February 2006 to 14 September 2011.

On the open market, the record shows 1 purchase worth €7,211 and 1 sale worth €291. Purchases outweigh sales by €6,920. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 9 share grants and 5 option exercises. 2011 to date brings no purchases and 1 sale.

The newest entry dates from 27 September 2011: a transaction of €279k, in Icagen, Inc. The last purchase on record was published on 19 August 2010, which is 5,926 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Kay Wagoner

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total
  • ●
    President and CEOExecutivesIcagen, Inc.
    384,036 USD0SEC
    64,006 shares@ US$6.00Common StockSEC:0001181431-11-050512:0
  • ◆
    President and CEOExecutivesIcagen, Inc.
    193,014 USD0SEC
    32,169 shares@ US$6.00Common StockSEC:0001181431-11-049113:0
  • ●
    President and CEOExecutivesIcagen, Inc.
    676,038 USD0SEC
    112,673 shares@ US$6.00Common StockSEC:0001209191-11-046933:0
  • ◆
    President and CEOExecutivesIcagen, Inc.
    47,835 USD0SEC
    8,026 shares@ US$5.96Common StockSEC:0001181431-11-045318:0
  • ▼
    President and CEOExecutivesIcagen, Inc.
    411 USD0SEC
    69 shares@ US$5.96Common StockSEC:0001181431-11-045318:1
  • ◆
    President and CEOExecutivesIcagen, Inc.
    0SEC
    100,000 shares0Common StockSEC:0001181431-11-009184:0
  • ▲
    President and CEOExecutivesIcagen, Inc.
    9,288 USD0SEC
    25,000 shares@ US$0.3715Common StockSEC:0001181431-10-042600:0
    Canonical exit: 15 Nov 2010 (T+90)
  • ◆
    President and CEOExecutivesIcagen, Inc.
    28,875 USD0SEC
    30,856 shares@ US$0.9358Common StockSEC:0001181431-10-004613:0
  • ◇
    President and CEOExecutivesIcagen, Inc.
    15,000 USD0SEC
    30,000 shares@ US$0.50Common StockSEC:0001181431-09-045417:0
  • ◇
    President and CEOExecutivesIcagen, Inc.
    15,000 USD0SEC
    30,000 shares@ US$0.50Common StockSEC:0001181431-09-035411:0
  • ◇
    President and CEOExecutivesIcagen, Inc.
    15,000 USD0SEC
    30,000 shares@ US$0.50Common StockSEC:0001181431-09-030039:0
  • ◆
    President and CEOExecutivesIcagen, Inc.
    0SEC
    311,290 shares0Common StockSEC:0001181431-09-004742:0
  • ◆
    President and CEOExecutivesIcagen, Inc.
    0SEC
    55,000 shares0Common StockSEC:0001181431-08-006289:0
  • ◆
    President and CEOExecutivesIcagen, Inc.
    0SEC
    35,610 shares0Common StockSEC:0001181431-07-053379:0
  • ◆
    President and CEOExecutivesIcagen, Inc.
    0SEC
    15,600 shares0Common StockSEC:0001181431-07-004414:0
  • ◇
    PRESIDENT AND CEOExecutivesIcagen, Inc.
    4,870 USD0SEC
    17,393 shares@ US$0.28COMMON STOCKSEC:0001181431-06-050731:0
  • ◇
    PRESIDENT AND CEOExecutivesIcagen, Inc.
    7,000 USD0SEC
    25,000 shares@ US$0.28COMMON STOCKSEC:0001181431-06-050731:1
  • ◆
    President and CEOExecutivesIcagen, Inc.
    0SEC
    31,250 shares0Common StockSEC:0001181431-06-008338:0

18 of 18 declarations